Kiromic Biopharma, Inc. Quarterly Assets in USD from Q4 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Kiromic Biopharma, Inc. quarterly Assets history and growth rate from Q4 2019 to Q3 2024.
Kiromic Biopharma, Inc. Assets for the quarter ending September 30, 2024 was $10.2M, a 28% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$10.2M	-$3.99M	-28%	Sep 30, 2024	10-Q	2024-11-08
Q2 2024	$12.5M	-$1.17M	-8.6%	Jun 30, 2024	10-Q	2024-08-09
Q1 2024	$12.6M	-$480K	-3.66%	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	$12.2M	+$202K	+1.68%	Dec 31, 2023	10-Q	2024-11-08
Q3 2023	$14.2M	+$1.21M	+9.33%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$13.6M	-$5.88M	-30.1%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$13.1M	-$12.8M	-49.4%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$12M	-$18.8M	-61.1%	Dec 31, 2022	10-K	2024-03-19
Q3 2022	$13M	-$25.9M	-66.6%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$19.5M	+$13.1M	+203%	Jun 30, 2022	10-Q	2022-08-12
Q1 2022	$25.9M	+$15.7M	+155%	Mar 31, 2022	10-Q	2022-05-13
Q4 2021	$30.7M	+$17.9M	+140%	Dec 31, 2021	10-K	2023-04-17
Q3 2021	$39M	+$35.8M	+1125%	Sep 30, 2021	10-Q	2022-03-11
Q2 2021	$6.44M			Jun 30, 2021	10-Q	2021-08-13
Q1 2021	$10.2M			Mar 31, 2021	10-Q	2021-05-14
Q4 2020	$12.8M	+$10.2M	+384%	Dec 31, 2020	10-K	2022-04-08
Q3 2020	$3.18M			Sep 30, 2020	10-Q	2020-11-30
Q4 2019	$2.65M			Dec 31, 2019	10-K	2021-03-31

* An asterisk sign (*) next to the value indicates that the value is likely invalid.